People who take GLP-1 drugs like Ozempic can lose weight even if they face disruptions in accessing the medications, which ...

Weight loss pills have been around for decades, but many were deemed unsafe by the FDA. Now, as better-regulated drugs hit the market, here’s what to know about their safety and side effects.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Protagonist is directly going up against Eli Lilly, which is advancing retatrutide, also a triple-G agonist, in a Phase II trial.

Mounjaro, the weight loss injection developed by pharmaceutical firm Lilly, is set to be prescribed on the NHS for the first time. Also known as tirzepatide, the drug will become available to around ...

Meanwhile, Lilly is notching win after win. Eli Lilly's position in the weight management market makes its stock attractive, considering how fast this area is projected to grow in the coming years.

A diet pill that lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass, could help patients lose weight without suffering brutal side effects.

A diet pill that lowers blood sugar and increases fat burning without negatively affecting appetite or muscle mass, could help patients lose weight without suffering brutal side effects. The potential ...